Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.3024USD
−141.11 MUSD
107.33 KUSD
624.32 M
About OPTHEA LIMITED
Sector
Industry
CEO
Frédéric Guerard
Website
Headquarters
South Yarra
Founded
1984
ISIN
AU000000OPT2
FIGI
BBG001R0KWJ4
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CKDXF is 0.2900 USD — it has decreased by 30.95% in the past 24 hours. Watch Opthea Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Opthea Limited stocks are traded under the ticker CKDXF.
We've gathered analysts' opinions on Opthea Limited future price: according to them, CKDXF price has a max estimate of 2.25 USD and a min estimate of 0.46 USD. Watch CKDXF chart and read a more detailed Opthea Limited stock forecast: see what analysts think of Opthea Limited and suggest that you do with its stocks.
CKDXF reached its all-time high on Sep 5, 2019 with the price of 2.5100 USD, and its all-time low was 0.2900 USD and was reached on Nov 14, 2023. View more price dynamics on CKDXF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CKDXF stock is 44.83% volatile and has beta coefficient of 1.25. Track Opthea Limited stock price on the chart and check out the list of the most volatile stocks — is Opthea Limited there?
Today Opthea Limited has the market capitalization of 285.05 M, it has decreased by 0.92% over the last week.
Yes, you can track Opthea Limited financials in yearly and quarterly reports right on TradingView.
Opthea Limited is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
CKDXF earnings for the last quarter are −0.16 USD per share, whereas the estimation was −0.12 USD resulting in a −36.67% surprise. The estimated earnings for the next quarter are −0.05 USD per share. See more details about Opthea Limited earnings.
Opthea Limited revenue for the last quarter amounts to 60.80 K USD despite the estimated figure of 25.00 K USD. In the next quarter revenue is expected to reach 39.00 K USD.
CKDXF net income for the last quarter is −100.36 M USD, while the quarter before that showed −64.50 M USD of net income which accounts for −55.60% change. Track more Opthea Limited financial stats to get the full picture.
No, CKDXF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Opthea Limited EBITDA is −169.76 M USD, and current EBITDA margin is −138.55 K%. See more stats in Opthea Limited financial statements.
Like other stocks, CKDXF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Opthea Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Opthea Limited technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Opthea Limited stock shows the strong sell signal. See more of Opthea Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.